Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhEpo for Neuroprotection in Very Preterm Infants
NCT00910234Phase 2Unknown
- Sponsor
- China Medical University Hospital
- Start
- Aug 2009
- Primary completion
- Jul 2011
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta in periventricular leukomalacia (PVL), Intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), sponsored by China Medical University Hospital. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
periventricular leukomalacia (PVL)Intraventricular hemorrhage (IVH)retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT00910234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910234.